Filing of the 2021 Universal Registration Document, containing the Annual Financial Report, and of the American “Form 20-F”


Filing of the Universal Registration Document 2021containing the Annual Financial Report, and the “ form 20-F” American

Paris the 23 February 2022. Sanofi announces that it has filed its 2021 Universal Registration Document containing the Annual Financial Report with the Autorité des marchés financiers (AMF) in France and its “Form 20-F” with the “Securities and Exchange Commission” (SEC) in United States.

The report of the Board of Directors on corporate governance as well as the report of the statutory auditors relating thereto; information relating to the fees paid to the statutory auditors; the information required under the description of the share buyback program; and information relating to social, environmental and societal responsibility (including the declaration of extra-financial performance and vigilance plan) also appears in the Universal Registration Document.

The documents can be consulted on the company’s website: www.sanofi.com/fr/investors/rapports-et-publications/rapports-financiers-et-rse.

The Universal Registration Document is also available on the AMF website (www.amf-france.org) and the “Form 20-F” on the SEC website (www.sec.gov). A printed version of these documents containing the audited financial statements can be obtained on request and free of charge.

AT in relation to Sanofi
We are an innovative, global health company driven by one purpose: to pursue the miracles of science to improve people’s lives. Our teams, present in a hundred countries, are working to transform the practice of medicine to make the impossible possible. We provide therapeutic solutions that can change the lives of patients and vaccines that protect millions of people around the world, guided by the ambition of sustainable development and our social responsibility.
Sanofi is listed on EURONEXT: SAN and NASDAQ: SNY

Media relations
Nicholas Obrist | + 33 6 77 21 27 55 | [email protected]
Victor Rouault | + 33 6 70 93 71 40 | [email protected]
Kate Conway | + 1 508 364 4931 | [email protected]

Investor Relations
Eva Schaefer-Jansen | + 33 7 86 80 56 39 | [email protected]
Arnaud Delepine | + 33 6 73 69 36 93 | [email protected]
Corentine Driancourt | + 33 6 40 56 92 21 | [email protected]
Felix Lauscher | + 1 908 612 7239 | [email protected]
Priya Nanduri | +1 908 981 5560 | [email protected]
Nathalie Pham | + 33 7 85 93 30 17 | [email protected]

Primary Logo



Source link -88